| Torasemide 10 mg Tablets PA22871/014/003 |
Torasemide |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Torasemide 5 mg Tablets PA22871/014/002 |
Torasemide |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Tradol 50 mg Effervescent tablets PA0074/094/001 |
Tramadol hydrochloride |
Rowa Pharmaceuticals Limited, |
Marketed |
| Tramadol /Paracetamol Rowa 37.5 mg/325 mg Film-coated Tablets PA0074/070/001 |
Tramadol hydrochloride, Paracetamol |
Rowa Pharmaceuticals Limited, |
Marketed |
| Tramadol Hydrochloride/Paracetamol 37.5 mg/325 mg Film-Coated Tablets PA1418/009/001 |
Tramadol hydrochloride, Paracetamol |
Athlone Pharmaceuticals Limited |
Not marketed |
| Trandate 100mg Film-Coated Tablets PA1638/006/002 |
Labetalol hydrochloride |
RPH Pharmaceuticals AB |
Marketed |
| Trandate 200mg Film-coated Tablets PA1638/006/003 |
Labetalol hydrochloride |
RPH Pharmaceuticals AB |
Marketed |
| Trandate 5 mg/ml Solution for Injection PA1638/006/001 |
Labetalol hydrochloride |
RPH Pharmaceuticals AB |
Marketed |
| Transiderm-Nitro 10milligram/24 hours Transdermal Patch PA23311/005/002 |
Glyceryl trinitrate |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Transiderm-Nitro 15milligrams/24 hours Transdermal Patch PA23311/005/003 |
Glyceryl trinitrate |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Transiderm-Nitro 5milligrams/24 hours Transdermal Patch PA23311/005/001 |
Glyceryl trinitrate |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Tranylcypromine 10 mg coated tablets PA1567/008/001 |
Tranylcypromine sulfate |
Activase Pharmaceuticals Limited |
Not marketed |
| Trazodone Hydrochloride 150 mg Film-Coated Tablets PA22871/015/001 |
Trazodone hydrochloride |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Trazodone Hydrochloride 50 mg/5 ml Oral Solution PA23176/005/001 |
Trazodone hydrochloride |
Lexon Pharmaceuticals (Ireland) Limited |
Marketed |
| Trazodone Hydrochloride Azure 100 mg hard capsules PA22871/018/002 |
Trazodone hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Trazodone Hydrochloride Azure 50 mg hard capsules PA22871/018/001 |
Trazodone hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Triapin 5 mg/5 mg prolonged release tablets PPA23080/015/001 |
Felodipine, Ramipril |
Merit Pharmaceuticals Limited |
— |
| Trimethoprim 10 mg/ml Oral Suspension PA1418/005/001 |
Trimethoprim |
Athlone Pharmaceuticals Limited |
Not marketed |
| Trimoptin Tablets 100 mg PA1418/008/001 |
Trimethoprim |
Athlone Pharmaceuticals Limited |
Marketed |
| Trimoptin Tablets 200 mg PA1418/008/002 |
Trimethoprim |
Athlone Pharmaceuticals Limited |
Marketed |
| Tropex 5% w/v Ear Drops Solution PA0074/002/001 |
Phenazone |
Rowa Pharmaceuticals Limited, |
Marketed |
| Tyvense 20 mg capsules, hard PA23211/005/001 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 30 mg capsules, hard PA23211/005/002 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 40 mg capsules, hard PA23211/005/003 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 50 mg capsules, hard PA23211/005/004 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 60 mg capsules, hard PA23211/005/005 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 70 mg capsules, hard PA23211/005/006 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Valaciclovir Bluefish 500 mg film-coated tablets PA1436/005/001 |
Valaciclovir |
Bluefish Pharmaceuticals AB |
Marketed |
| Valsartan Rowa 160 mg film-coated tablets PA0074/083/003 |
Valsartan |
Rowa Pharmaceuticals Limited |
Not marketed |
| Valsartan Rowa 320 mg film-coated tablets PA0074/083/004 |
Valsartan |
Rowa Pharmaceuticals Limited |
Not marketed |
| Valsartan Rowa 40 mg film-coated tablets PA0074/083/001 |
Valsartan |
Rowa Pharmaceuticals Limited |
Not marketed |
| Valsartan Rowa 80 mg film-coated tablets PA0074/083/002 |
Valsartan |
Rowa Pharmaceuticals Limited |
Not marketed |
| Venlablue XL 150mg Prolonged Release Capsules, Hard PA1436/006/002 |
Venlafaxine |
Bluefish Pharmaceuticals AB |
Marketed |
| Venlablue XL 75 mg prolonged-release capsules, hard PA1436/006/001 |
Venlafaxine |
Bluefish Pharmaceuticals AB |
Marketed |
| Versatis 700 mg medicated plaster PPA23080/013/001 |
Lidocaine |
Merit Pharmaceuticals Limited |
— |
| Vesomni 6 mg/0.4 mg modified-release tablets PPA23080/033/001 |
Solifenacin succinate, Tamsulosin hydrochloride |
Merit Pharmaceuticals Limited |
— |
| VIMOVO 500 mg/20 mg modified-release tablets PPA23080/031/001 |
Naproxen, Esomeprazole |
Merit Pharmaceuticals Limited |
— |
| Voquily 1 mg/ml oral solution PA22757/001/001 |
Melatonin |
RAD Neurim Pharmaceuticals EEC SARL |
Not marketed |
| VPRIV 400 Units powder for solution for infusion EU/1/10/646/002-006 |
Velaglucerase alfa |
Shire Pharmaceuticals Ireland Limited |
— |
| Vyxeos liposomal 44 mg/100 mg powder for concentrate for solution for infusion EU/1/18/1308/001-003 |
Cytarabine, DAUNOMYCIN HYDROCHLORIDE |
Jazz Pharmaceuticals Ireland Limited |
— |
| Warfant 1 mg Tablets PA0073/139/001 |
WARFARIN SODIUM |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Warfant 3 mg Tablets PA0073/139/002 |
WARFARIN SODIUM |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Warfant 5 mg Tablets PA0073/139/003 |
WARFARIN SODIUM |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Xagrid 0.5 mg hard capsules EU/1/04/295/001 |
Anagrelide hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| XEOMIN 100 units powder for solution for injection PA1907/001/002 |
Clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins |
Merz Pharmaceuticals GmbH |
Marketed |
| XEOMIN 200 units powder for solution for injection PA1907/001/003 |
Clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins |
Merz Pharmaceuticals GmbH |
Marketed |
| XEOMIN 50 units powder for solution for injection PA1907/001/001 |
Clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins |
Merz Pharmaceuticals GmbH |
Marketed |
| Xtex 250 mg /5 ml oral solution PA0074/071/001 |
Carbocisteine |
Rowa Pharmaceuticals Limited, |
Marketed |
| ZANIDIP 10 mg Film-coated Tablets PPA23080/034/001 |
Lercanidipine hydrochloride |
Merit Pharmaceuticals Limited |
— |
| ZANIDIP 20 mg Film-coated Tablets PPA23080/034/002 |
Lercanidipine hydrochloride |
Merit Pharmaceuticals Limited |
— |